Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections Seattle, Washington March 4-7, 2019 Back

Tweet

Weight Gain in HIV – Integrase       PLENARY TALK - Obesity & Weight Gain on Antiretroviral Therapy - (03/11/19)   Integrase Strand Transfer Inhibitors are Associated With Weight Gain in Women - (03/25/19)   DIFFERENTIAL BMI CHANGES FOLLOWING PI- AND INSTI- BASED ART INITIATION BY SEX AND RACE - (03/13/19)   RISK FACTORS FOR EXCESS WEIGHT GAIN FOLLOWING SWITCH TO INTEGRASE INHIBITOR-BASED ART - (03/11/19)   Pharmacogenetics of Weight Gain after Switch from Efavirenz to Integrase Inhibitors - (03/11/19)   Weight Gain During Treatment Among 3,468 Treatment-Experienced Adults with HIV - (03/11/19)   GREATER WEIGHT GAIN AMONG TREATMENT-NAIVE PERSONS STARTING INTEGRASE INHIBITORS - (03/11/19)   Weight Gain among Virally Suppressed Persons who Switch to INSTI-Based ART, The HIV Outpatient Study - (03/11/19)   The Impact of Weight Gain and Sex on Immune Activation Following Initiation of ART - (03/11/19)   INTEGRASE STRAND TRANSFER INHIBITORS ARE ASSOCIATED WITH WEIGHT GAIN IN WOMEN - (03/11/19)